Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections

Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections

Eilish McCann,1 Anita H Sung,1 Gang Ye,2 Latha Vankeepuram,2 Ying P Tabak2 1Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA; 2Digital Health, Medical Affairs, Becton, Dickinson and Company, Franklin Lakes, NJ, USACorrespondence: Eilish McCannCe...

Full description

Bibliographic Details
Main Authors: McCann E, Sung AH, Ye G, Vankeepuram L, Tabak YP
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
bacterial drug resistance
health care costs
hospital costs
patient outcome assessment
risk assessment
Online Access:https://www.dovepress.com/contributing-factors-to-the-clinical-and-economic-burden-of-patients-w-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/contributing-factors-to-the-clinical-and-economic-burden-of-patients-w-peer-reviewed-article-CEOR

Similar Items